Barclays’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.01M | Buy |
346,500
+253,961
| +274% | +$6.6M | ﹤0.01% | 1221 |
|
|
2025
Q1 | $2.27M | Sell |
92,539
-8,718
| -9% | -$214K | ﹤0.01% | 1952 |
|
|
2024
Q4 | $2.91M | Buy |
101,257
+10,737
| +12% | +$308K | ﹤0.01% | 1970 |
|
|
2024
Q3 | $3.42M | Buy |
90,520
+69,523
| +331% | +$2.62M | ﹤0.01% | 1791 |
|
|
2024
Q2 | $663K | Buy |
20,997
+4,644
| +28% | +$147K | ﹤0.01% | 2355 |
|
|
2024
Q1 | $718K | Buy |
+16,353
| New | +$718K | ﹤0.01% | 2617 |
|